ePrints

Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery

Lookup NU author(s): Dr Edward Okello

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Salvia officinalis (sage) has previously been shown both to possess in vitro cholinesterase inhibiting properties, and to enhance mnemonic performance and improve mood in healthy young participants. In this double-blind, placebo-controlled, crossover study, 30 healthy participants attended the laboratory on three separate days, 7 days apart, receiving a different treatment in counterbalanced order on each occasion (placebo, 300, 600 mg dried sage leaf). On each day mood was assessed predose and at 1 and 4 h postdose. Each mood assessment comprised completion of Bond-Lader mood scales and the State Trait Anxiety Inventor/ (STAI) before and after 20 min performance of the Defined Intensity Stress Simulator (DISS) computerized multitasking battery. In a concomitant investigation, an extract of the sage leaf exhibited dose-dependent, in vitro inhibition of acetylcholinesterase and, to a greater extent, butyrylcholinesterase. Both doses of sage led to improved ratings of mood in the absence of the stressor (that is, in pre-DISS mood scores) postdose, with the lower dose reducing anxiety and the higher dose increasing 'alertness', 'calmness' and 'contentedness' on the Bond-Lader mood scales. The reduced anxiety effect following the lower dose was, however, abolished by performing the DISS, with the same dose also being associated with a reduction of alertness during performance. Task performance on the DISS battery was improved for the higher dose at both postdose sessions, but reduced for the lower dose at the later testing session. The results confirm previous observations of the cholinesterase inhibiting properties of S. officinalis, and improved mood and cognitive performance following the administration of single doses to healthy young participants. © 2006 Nature Publishing Group All rights reserved.

Publication metadata

Author(s): Kennedy DO, Pace S, Haskell C, Okello EJ, Milne A, Scholey AB

Publication type: Article

Publication status: Published

Journal: Neuropsychopharmacology

Year: 2006

Volume: 31

Issue: 4

Pages: 845-852

ISSN (print): 0893-133X

ISSN (electronic): 1740-634X

Publisher: Nature Publishing Group

URL: http://dx.doi.org/10.1038/sj.npp.1300907

DOI: 10.1038/sj.npp.1300907

PubMed id: 16205785

Altmetrics

Share